Facebook Linkedin RSS Twitter Youtube
Home 2023

Cyclosporine

Poxvirus Therapy: Existing Drugs May Offer New, More Durable Approach
Featured

Poxvirus Therapy: Existing Drugs May Offer New, More Durable Approach

In Race to Supply Smallest Antibodies, Cows Outpace Camelids
Drug Discovery

In Race to Supply Smallest Antibodies, Cows Outpace Camelids

Auven to Sell Subsidiary, Dry Eye Disease Candidate to Sun Pharma
Industry News

Auven to Sell Subsidiary, Dry Eye Disease Candidate to Sun Pharma

Biologics Fill Void in Arthritis Treatment
Insights

Biologics Fill Void in Arthritis Treatment

Altacor Acquires OphthalmoPharma’s Latanoprost and Cyclosporin A Prodrug Candidates
News

Altacor Acquires OphthalmoPharma’s Latanoprost and Cyclosporin A Prodrug Candidates

FDA Clears Novartis’ Zortress for Preventing Organ Rejection in Kidney Transplant Patients
Drug Discovery

FDA Clears Novartis’ Zortress for Preventing Organ Rejection in Kidney Transplant Patients

BMS’ Transplant-Rejection Drug Passes FDA’s Advisory Panel
Drug Discovery

BMS’ Transplant-Rejection Drug Passes FDA’s Advisory Panel

Novartis Negotiates Rights to Debiopharm’s Mid-Stage HCV Candidate
News

Novartis Negotiates Rights to Debiopharm’s Mid-Stage HCV Candidate

Pfizer Gains 39 Generic Therapies from Aurobindo
News

Pfizer Gains 39 Generic Therapies from Aurobindo

Maas Biolab Awarded $2.1M to Enable Studies on Intrathecal Delivery of ALS Drug
News

Maas Biolab Awarded $2.1M to Enable Studies on Intrathecal Delivery of ALS Drug

12Page 1 of 2
Copyright © 2024 Genetic Engineering & Biotechnology News. All Rights Reserved.